QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.54 (-0.82%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.32 (+0.28%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.54 (-0.82%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.32 (+0.28%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.54 (-0.82%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.32 (+0.28%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.54 (-0.82%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.32 (+0.28%)

aTyr Pharma (LIFE) News Today

$1.90
-0.10 (-5.00%)
(As of 05:26 PM ET)
SourceHeadline
globenewswire.com logoaTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
globenewswire.com - February 28 at 8:00 AM
finance.yahoo.com logoWe Think aTyr Pharma (NASDAQ:LIFE) Can Afford To Drive Business Growth
finance.yahoo.com - February 23 at 3:28 PM
MarketBeat logoaTyr Pharma (NASDAQ:LIFE) Receives Buy Rating from HC Wainwright
americanbankingnews.com - February 22 at 4:42 AM
finance.yahoo.com logoaTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
finance.yahoo.com - February 21 at 11:39 AM
marketbeat.com logoaTyr Pharma (NASDAQ:LIFE) Rating Reiterated by HC Wainwright
marketbeat.com - February 21 at 11:19 AM
globenewswire.com logoaTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
globenewswire.com - February 21 at 8:00 AM
MarketBeat logoaTyr Pharma (NASDAQ:LIFE) Share Price Crosses Above 200-Day Moving Average of $1.51
americanbankingnews.com - February 20 at 3:44 AM
marketbeat.com logoaTyr Pharma (NASDAQ:LIFE) Shares Pass Above 200 Day Moving Average of $1.51
marketbeat.com - February 20 at 3:44 AM
MarketBeat logoaTyr Pharma, Inc. (NASDAQ:LIFE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
americanbankingnews.com - February 20 at 1:36 AM
marketbeat.com logoaTyr Pharma, Inc. (NASDAQ:LIFE) Given Average Recommendation of "Moderate Buy" by Brokerages
marketbeat.com - February 20 at 1:36 AM
investorplace.com logoThe 3 Best Penny Stocks to Buy in February 2024
investorplace.com - February 15 at 7:49 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: aTyr Pharma (LIFE), CVS Health (CVS) and Science 37 (SNCE)
markets.businessinsider.com - February 9 at 12:46 PM
marketbeat.com logoaTyr Pharma (NASDAQ:LIFE) Stock Price Crosses Above 200 Day Moving Average of $1.52
marketbeat.com - February 7 at 6:51 AM
finance.yahoo.com logoAfter losing 23% in the past year, aTyr Pharma, Inc. (NASDAQ:LIFE) institutional owners must be relieved by the recent gain
finance.yahoo.com - February 3 at 10:38 AM
marketbeat.com logoaTyr Pharma, Inc. (NASDAQ:LIFE) Sees Significant Drop in Short Interest
marketbeat.com - January 30 at 2:41 PM
finance.yahoo.com logoaTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
finance.yahoo.com - January 29 at 1:01 PM
finance.yahoo.com logoaTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
finance.yahoo.com - January 18 at 8:07 AM
markets.businessinsider.com logoPromising Potential of aTyr Pharma’s Efzofitimod in Treating Rheumatoid Arthritis and Associated Lung Disease Underpins Buy Rating
markets.businessinsider.com - November 15 at 1:40 AM
finance.yahoo.com logoaTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
finance.yahoo.com - November 13 at 1:00 PM
finance.yahoo.com logoaTyr Pharma's Market Cap Drops To US$66m Leaving Insiders With Losses
finance.yahoo.com - November 13 at 1:00 PM
msn.com logoaTyr Pharma files for $300M mixed-shelf offering
msn.com - November 13 at 7:59 AM
markets.businessinsider.com logoRBC Capital Keeps Their Buy Rating on aTyr Pharma (LIFE)
markets.businessinsider.com - November 11 at 11:34 PM
markets.businessinsider.com logoRobust Financial Health and Promising Clinical Progress Prompt ‘Buy’ Rating for aTyr Pharma
markets.businessinsider.com - November 10 at 8:27 PM
msn.com logoaTyr Pharma GAAP EPS of -$0.20, revenue of $0.3M
msn.com - November 10 at 3:27 PM
markets.businessinsider.com logoPalisade Bio Reports Third Quarter 2023 Financial Results and Provides Business Outlook
markets.businessinsider.com - November 10 at 10:27 AM
finance.yahoo.com logoaTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
finance.yahoo.com - November 9 at 6:36 PM
finance.yahoo.com logoaTyr Pharma to Present at November Investor Conferences
finance.yahoo.com - November 1 at 9:28 AM
finance.yahoo.com logoaTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
finance.yahoo.com - October 31 at 8:52 AM
markets.businessinsider.com logoPiper Sandler Sticks to Its Buy Rating for aTyr Pharma (LIFE)
markets.businessinsider.com - October 4 at 1:38 PM
markets.businessinsider.com logoBuy Rating for aTyr Pharma: Promising Developments in Efzofitimod Clinical Trials and Potential Expansion Opportunities
markets.businessinsider.com - September 28 at 2:13 PM
markets.businessinsider.com logoaTyr Pharma (LIFE) Gets a Buy from Piper Sandler
markets.businessinsider.com - September 26 at 9:16 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: aTyr Pharma (LIFE), Genfit SA (GNFT) and Boston Scientific (BSX)
markets.businessinsider.com - September 21 at 7:46 AM
finance.yahoo.com logoaTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
finance.yahoo.com - September 11 at 8:50 AM
finance.yahoo.com logoDown -9.64% in 4 Weeks, Here's Why You Should You Buy the Dip in Atyr Pharma (LIFE)
finance.yahoo.com - August 30 at 5:33 PM
finance.yahoo.com logoWe're Hopeful That aTyr Pharma (NASDAQ:LIFE) Will Use Its Cash Wisely
finance.yahoo.com - August 30 at 8:25 AM
marketbeat.com logoaTyr Pharma, Inc. (NASDAQ:LIFE) Given Average Recommendation of "Moderate Buy" by Analysts
marketbeat.com - August 29 at 1:24 AM
finance.yahoo.com logoaTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - August 24 at 6:54 PM
marketbeat.com logoQ3 2023 EPS Estimates for aTyr Pharma, Inc. (NASDAQ:LIFE) Increased by HC Wainwright
marketbeat.com - August 14 at 2:16 AM
marketbeat.com logoBrokers Issue Forecasts for aTyr Pharma, Inc.'s FY2026 Earnings (NASDAQ:LIFE)
marketbeat.com - August 11 at 1:16 PM
markets.businessinsider.com logoJonesTrading Sticks to Its Buy Rating for aTyr Pharma (LIFE)
markets.businessinsider.com - August 11 at 12:35 AM
finance.yahoo.com logoaTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update
finance.yahoo.com - August 9 at 5:27 PM
marketbeat.com logoaTyr Pharma (NASDAQ:LIFE) Upgraded to "Hold" at StockNews.com
marketbeat.com - August 4 at 4:14 AM
marketbeat.com logoaTyr Pharma, Inc. (NASDAQ:LIFE) Receives Average Rating of "Moderate Buy" from Brokerages
marketbeat.com - August 4 at 2:46 AM
msn.com logoAtyr Pharma (LIFE) Price Target Increased by 8.21% to 21.76
msn.com - August 2 at 5:49 PM
finance.yahoo.com logoaTyr Pharma, Inc. (NASDAQ:LIFE) is a favorite amongst institutional investors who own 56%
finance.yahoo.com - July 20 at 8:28 AM
marketbeat.com logoaTyr Pharma, Inc. (NASDAQ:LIFE) Short Interest Up 6.9% in June
marketbeat.com - July 20 at 4:14 AM
marketbeat.com logoaTyr Pharma, Inc. (NASDAQ:LIFE) Receives Average Recommendation of "Moderate Buy" from Analysts
marketbeat.com - July 10 at 2:19 AM
msn.com logoOppenheimer Downgrades Atyr Pharma (LIFE)
msn.com - July 5 at 10:58 PM
msn.com logoaTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analyst
msn.com - July 5 at 5:57 PM
markets.businessinsider.com logo7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023
markets.businessinsider.com - June 28 at 8:48 AM
Get aTyr Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIFE and its competitors with MarketBeat's FREE daily newsletter.



LIFE Media Mentions By Week

LIFE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LIFE
News Sentiment

0.45

0.70

Average
Medical
News Sentiment

LIFE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LIFE Articles
This Week

5

1

LIFE Articles
Average Week

Get aTyr Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIFE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:LIFE) was last updated on 2/28/2024 by MarketBeat.com Staff